NCT06595602 Intelligent Lung Support in the Intensive Care Unit
| NCT ID | NCT06595602 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Technische Universität Dresden |
| Condition | Mechanical Ventilation |
| Study Type | OBSERVATIONAL |
| Enrollment | 530 participants |
| Start Date | 2025-05-25 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 530 participants in total. It began in 2025-05-25 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this observational study is to test the IntelliLung decision support system based on artificial intelligence. This system is intended to help to set the ventilator. The study includes patients with and without ARDS (acute respiratory distress syndrome) who are receiving invasive mechanical ventilation, as well as patients with additional extracorporeal lung support. The study will be conducted in several centers. The main question of the study: How well do the mechanical ventilation settings of healthcare staff match the recommendations of the IntelliLung system?
Eligibility Criteria
Inclusion Criteria: 1. Male and female patients, age ⪰18 years 2. Written informed consent 3. Invasively mechanically ventilated patients expected to be intubated for more than 24 hours. Exclusion Criteria: 1. Expected to die within ≤48 hours 2. Participation in an interventional mechanical ventilation trial 3. Mechanical Ventilation with a closed-loop ventilation mode 4. Persons dependent on the sponsor and/or investigator 5. Subjects who are currently imprisoned or otherwise in confinement ordered by law or other official authorities
Contact & Investigator
Jakob Wittenstein
PRINCIPAL INVESTIGATOR
epartment of Anesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
Frequently Asked Questions
Who can join the NCT06595602 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mechanical Ventilation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06595602 currently recruiting?
Yes, NCT06595602 is actively recruiting participants. Contact the research team at jakob.wittenstein@ukdd.de for enrollment information.
Where is the NCT06595602 trial being conducted?
This trial is being conducted at Dresden, Germany, Genova, Italy, Warsaw, Poland, Madrid, Spain and 1 additional location.
Who is sponsoring the NCT06595602 clinical trial?
NCT06595602 is sponsored by Technische Universität Dresden. The principal investigator is Jakob Wittenstein at epartment of Anesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany. The trial plans to enroll 530 participants.